Overview A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease. Phase: Phase 3 Details Lead Sponsor: SK Chemicals Co., Ltd.SK Chemicals Co.,Ltd.